Clinical Endpoint
What a definition is not
A definition is SPEQ’s plain-language decode of how a term is used in practice, cited to the documents that define it. It is a practitioner reference, not legal or regulatory advice, it does not replace the definition in the source, and where a regulator’s wording differs the regulator’s wording governs.
A pre-specified variable measured in a clinical trial that reflects a clinically meaningful effect of the intervention, used to assess efficacy or safety. Endpoints are classified as primary, secondary, or exploratory, and each must be precisely defined, including timing, measurement method, and how intercurrent events are handled under the estimand framework.
The primary endpoint is the main basis for the trial’s statistical conclusion and drives its sample-size calculation; secondary endpoints provide supporting evidence, and exploratory endpoints generate hypotheses for future study without confirmatory weight.
A distinction with real regulatory consequence is between hard clinical endpoints — events like survival or hospitalization that are inherently meaningful to patients — and surrogate endpoints, such as a biomarker, which substitute for a clinical outcome and require independent validation that they actually predict clinical benefit.
Under the ICH E9(R1) estimand framework, the endpoint alone does not fully define what a trial is estimating — it must be paired with a defined population, treatment comparison, and a pre-specified strategy for handling intercurrent events such as treatment discontinuation.
- —The primary endpoint drives sample size calculation and the trial’s statistical success criteria.
- —Surrogate endpoints substitute for a clinical outcome and require independent validation of their link to clinical benefit.
- —Endpoint definitions must specify exact timing, measurement instrument, and handling of missing or discordant data.
- —Under ICH E9(R1), the endpoint is only one component of the estimand, alongside population and intercurrent-event strategy.
ICH E9 Statistical Principles for Clinical Trials; ICH E9(R1) Addendum on Estimands and Sensitivity Analysis in Clinical Trials; ICH E8(R1) General Considerations for Clinical Studies
Frequently asked questions
What is Clinical Endpoint?
A pre-specified variable measured in a clinical trial that reflects a clinically meaningful effect of the intervention, used to assess efficacy or safety. Endpoints are classified as primary, secondary, or exploratory, and each must be precisely defined, including timing, measurement method, and how intercurrent events are handled under the estimand framework.
Which regulations cover Clinical Endpoint?
ICH E9 Statistical Principles for Clinical Trials; ICH E9(R1) Addendum on Estimands and Sensitivity Analysis in Clinical Trials; ICH E8(R1) General Considerations for Clinical Studies